Vyome Holdings, Inc. HIND · Stock Open Vyome Holdings, Inc. in new tab
Vyome Holdings, Inc. Analysis (HIND)
Is Vyome Holdings, Inc. a good investment? Vyome Holdings, Inc. (HIND) is currently trading at 2.04 USD. Market analysts have a consensus price target of 8.83 USD. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 1.08. This relatively low multiple may signal that Vyome Holdings, Inc. is undervalued compared to historical market norms.
Earnings Schedule: Vyome Holdings, Inc. is expected to release its next earnings report on Nov. 13, 2026.
Investor FAQ
Does Vyome Holdings, Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Vyome Holdings, Inc.?
Vyome Holdings, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Nov. 13, 2026. The company currently has a trailing EPS of 1.78.
Company Profile
Vyome Holdings, Inc., a clinical-stage specialty pharmaceutical company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States. It operates through Pharmaceutical and Biotechnology segments. The company's lead product candidate VT-1953, a dual DNA Gyrase/Topoisomerase inhibitor and immunomodulator in a topical gel formulation that is in phase 2 clinical stage for the treatment of bacterial conjunctivitis. It also develops VT-1908, a topical eye drop is an inosine 5'-monophosphate dehydrogenase enzyme inhibitor to treat immunoinflammatory conditions of the eye; and VB-1953, which is in phase 2 clinical stage for the treatment of inflammatory acne. In addition, the company develops antifungal products using the molecular replacement therapy (MRT) platform. It has a collaboration and license agreement with Sun Pharma Laboratories Limited to develop and commercialize next-generation antifungal products. The company is based in Cambridge, Massachusetts.
| Split Date | Split Ratio to 1 |
|---|---|
| July 25, 2019 | 1:10 |
| Dec. 23, 2022 | 1:50 |
| Sept. 23, 2024 | 1:50 |
| May 9, 2025 | 1:25 |
| Aug. 15, 2025 | 1:4 |
Community Discussion